Singapore’s manufacturing sector showed mixed performance in February, with headline output edging down 0.1% year-on-year, weighed by a sharp contraction in the biomedical cluster.
Biomedical Decline Masks Underlying Strength
Data from Singapore’s Economic Development Board (EDB) revealed that biomedical output plunged 27.3% YoY, significantly dragging overall manufacturing performance.
However, excluding this volatile segment, manufacturing output actually grew 3.9%, indicating underlying resilience in core industrial activity.
Electronics Sector Provides Support
The electronics cluster recorded growth, offering a key pillar of support amid broader weakness.
In contrast, most other major clusters reported declines in output, suggesting uneven recovery across the sector.
Monthly Contraction Signals Near-Term Weakness
On a month-on-month basis, the data points to short-term softness:
- Overall output fell 7.2% (seasonally adjusted)
- Excluding biomedical: down 9.4%
This suggests that momentum slowed significantly in February, potentially reflecting softer external demand or production volatility.
Outlook: Volatility Likely to Persist
Singapore’s manufacturing sector remains highly sensitive to global demand cycles, particularly in electronics and pharmaceuticals.
The sharp divergence between biomedical and non-biomedical output highlights the sector’s volatility, which could continue to distort headline figures in the near term.
Investor Takeaways
- Singapore manufacturing output declined 0.1% YoY, mainly due to a 27.3% drop in biomedical production.
- Excluding biomedical, factory output grew 3.9%, indicating underlying strength.
- The electronics sector remains a key growth driver.
- Month-on-month contraction (-7.2%) signals short-term weakness in industrial activity.
- Investors should focus on core manufacturing trends excluding volatile segments for a clearer outlook.
Comments
Post a Comment